US Stock MarketDetailed Quotes

ADILW Adial Pharmaceuticals Inc C/ Wts 31/07/2023 (To Pur Com)

Watchlist

0.0009
0.00000.00%

Trading Jul 28 09:30 ET

0Market Cap0.00P/E (TTM)

Adial Pharmaceuticals Inc C/ Wts 31/07/2023 (To Pur Com) Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

(FY)Dec 31, 2021

(Q4)Dec 31, 2021

(Q3)Sep 30, 2021

(Q2)Jun 30, 2021

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

7.93%-2.3M

6.39%-11.19M

26.22%-1.75M

3.56%-3.4M

-10.33%-3.53M

12.19%-2.5M

-56.55%-11.95M

9.22%-2.37M

-59.82%-3.53M

-225.15%-3.2M

Net income from continuing operations

0.07%-2.91M

34.45%-12.73M

50.84%-2.87M

27.99%-3.11M

13.36%-3.85M

39.84%-2.91M

-78.31%-19.42M

-68.07%-5.83M

-29.44%-4.32M

-145.21%-4.44M

Operating gains losses

----

---22.13K

--0

---29.09K

Depreciation and amortization

7.68%15.84K

9.79%60.5K

-5.15%15.55K

24.28%15.26K

7.24%14.98K

18.01%14.71K

9,670.57%55.11K

11,524.11%16.39K

8,609.22%12.28K

9,807.80%13.97K

Deferred tax

----

99.47%-502

----

---94.08K

----

Other non cash items

109.59%14K

-285.29%-522K

-501.70%-325K

-127.32%-75K

-64.43%24K

-2,226.69%-146K

--281.71K

---54.01K

--274.52K

--67.48K

Change In working capital

126.65%117.61K

-193.35%-1.37M

-40.25%691.64K

-15.18%-791.9K

-341.43%-825.56K

-167.62%-441.24K

17.63%1.46M

138.72%1.16M

-253.07%-687.54K

-20.54%341.95K

-Change in prepaid assets

2.01%126.09K

-212.95%-378.71K

-40.26%242.46K

44.12%-237.62K

-428.72%-507.16K

-38.30%123.6K

107.37%335.29K

459.74%405.89K

-1,217.24%-425.21K

11.57%154.28K

-Change in payables and accrued expense

100.92%5.1K

-180.48%-938.77K

-39.43%462.05K

-110.68%-541.69K

-254.37%-306.1K

-219.56%-553.03K

7.68%1.17M

84.97%762.78K

-162.54%-257.11K

-32.11%198.29K

-Change in other current liabilities

-14.96%-13.58K

-32.80%-49.59K

-15.90%-12.87K

-141.21%-12.59K

-15.89%-12.31K

-13.71%-11.81K

---37.34K

---11.11K

---5.22K

---10.62K

Cash from discontinued investing activities

Operating cash flow

7.93%-2.3M

6.39%-11.19M

26.22%-1.75M

3.56%-3.4M

-10.33%-3.53M

12.19%-2.5M

-56.55%-11.95M

9.22%-2.37M

-59.82%-3.53M

-225.15%-3.2M

Investing cash flow

Cash flow from continuing investing activities

90.28%-34.02K

-33.73K

Net PPE purchase and sale

----

--0

----

---64.61K

--0

---33.73K

Net business purchase and sale

----

--0

----

--30.59K

--0

Cash from discontinued investing activities

Investing cash flow

----

--0

----

90.28%-34.02K

--0

---33.73K

Financing cash flow

Cash flow from continuing financing activities

-93.32%609.61K

-33.12%9.13M

-99.93%1.87K

123.59%9.12M

143.34%13.64M

1.25M

478.94%5.5M

-39.68%2.81M

Net common stock issuance

-93.32%609.61K

-22.35%9.12M

--0

245.46%9.12M

127.84%11.75M

--800K

1,000.00%5.5M

-39.68%2.81M

Proceeds from stock option exercised by employees

----

-99.90%1.87K

--0

----

320.99%1.89M

--455K

--0

Cash from discontinued financing activities

Financing cash flow

-93.32%609.61K

-33.12%9.13M

--0

-99.93%1.87K

123.59%9.12M

143.34%13.64M

--1.25M

478.94%5.5M

-39.68%2.81M

Net cash flow

Beginning cash position

-33.99%4M

37.74%6.06M

-19.88%5.75M

75.76%9.16M

125.07%12.69M

37.74%6.06M

-35.06%4.4M

-2.51%7.18M

-39.59%5.21M

13.86%5.64M

Current changes in cash

-125.49%-1.69M

-224.04%-2.06M

-56.60%-1.75M

-272.76%-3.4M

-725.24%-3.53M

435.82%6.63M

169.91%1.66M

62.28%-1.12M

256.56%1.97M

-111.66%-428.06K

End cash Position

-81.78%2.31M

-33.99%4M

-19.88%5.75M

75.76%9.16M

125.07%12.69M

37.74%6.06M

-2.51%7.18M

-39.59%5.21M

Free cash flow

7.93%-2.3M

6.89%-11.19M

26.22%-1.75M

3.56%-3.4M

-9.19%-3.53M

13.14%-2.5M

-57.39%-12.01M

9.22%-2.37M

-59.82%-3.53M

-228.58%-3.24M

Currency Unit

USD

Audit Opinions

Unqualified Opinion with Explanatory Notes

Unqualified Opinion

	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022	(FY)Dec 31, 2021	(Q4)Dec 31, 2021	(Q3)Sep 30, 2021	(Q2)Jun 30, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	7.93%-2.3M	6.39%-11.19M	26.22%-1.75M	3.56%-3.4M	-10.33%-3.53M	12.19%-2.5M	-56.55%-11.95M	9.22%-2.37M	-59.82%-3.53M	-225.15%-3.2M
Net income from continuing operations	0.07%-2.91M	34.45%-12.73M	50.84%-2.87M	27.99%-3.11M	13.36%-3.85M	39.84%-2.91M	-78.31%-19.42M	-68.07%-5.83M	-29.44%-4.32M	-145.21%-4.44M
Operating gains losses	----	----	----	----	----	----	---22.13K	--0	--0	---29.09K
Depreciation and amortization	7.68%15.84K	9.79%60.5K	-5.15%15.55K	24.28%15.26K	7.24%14.98K	18.01%14.71K	9,670.57%55.11K	11,524.11%16.39K	8,609.22%12.28K	9,807.80%13.97K
Deferred tax	----	99.47%-502	----	----	----	----	---94.08K	----	----	----
Other non cash items	109.59%14K	-285.29%-522K	-501.70%-325K	-127.32%-75K	-64.43%24K	-2,226.69%-146K	--281.71K	---54.01K	--274.52K	--67.48K
Change In working capital	126.65%117.61K	-193.35%-1.37M	-40.25%691.64K	-15.18%-791.9K	-341.43%-825.56K	-167.62%-441.24K	17.63%1.46M	138.72%1.16M	-253.07%-687.54K	-20.54%341.95K
-Change in prepaid assets	2.01%126.09K	-212.95%-378.71K	-40.26%242.46K	44.12%-237.62K	-428.72%-507.16K	-38.30%123.6K	107.37%335.29K	459.74%405.89K	-1,217.24%-425.21K	11.57%154.28K
-Change in payables and accrued expense	100.92%5.1K	-180.48%-938.77K	-39.43%462.05K	-110.68%-541.69K	-254.37%-306.1K	-219.56%-553.03K	7.68%1.17M	84.97%762.78K	-162.54%-257.11K	-32.11%198.29K
-Change in other current liabilities	-14.96%-13.58K	-32.80%-49.59K	-15.90%-12.87K	-141.21%-12.59K	-15.89%-12.31K	-13.71%-11.81K	---37.34K	---11.11K	---5.22K	---10.62K
Cash from discontinued investing activities
Operating cash flow	7.93%-2.3M	6.39%-11.19M	26.22%-1.75M	3.56%-3.4M	-10.33%-3.53M	12.19%-2.5M	-56.55%-11.95M	9.22%-2.37M	-59.82%-3.53M	-225.15%-3.2M
Investing cash flow
Cash flow from continuing investing activities		0	0	0			90.28%-34.02K	0	0	-33.73K
Net PPE purchase and sale	----	--0	--0	--0	----	----	---64.61K	--0	--0	---33.73K
Net business purchase and sale	----	--0	--0	--0	----	----	--30.59K	--0	--0	--0
Cash from discontinued investing activities
Investing cash flow	----	--0	--0	--0	----	----	90.28%-34.02K	--0	--0	---33.73K
Financing cash flow
Cash flow from continuing financing activities	-93.32%609.61K	-33.12%9.13M	0	0	-99.93%1.87K	123.59%9.12M	143.34%13.64M	1.25M	478.94%5.5M	-39.68%2.81M
Net common stock issuance	-93.32%609.61K	-22.35%9.12M	--0	--0	--0	245.46%9.12M	127.84%11.75M	--800K	1,000.00%5.5M	-39.68%2.81M
Proceeds from stock option exercised by employees	----	-99.90%1.87K	--0	--0	----	----	320.99%1.89M	--455K	--0	--0
Cash from discontinued financing activities
Financing cash flow	-93.32%609.61K	-33.12%9.13M	--0	--0	-99.93%1.87K	123.59%9.12M	143.34%13.64M	--1.25M	478.94%5.5M	-39.68%2.81M
Net cash flow
Beginning cash position	-33.99%4M	37.74%6.06M	-19.88%5.75M	75.76%9.16M	125.07%12.69M	37.74%6.06M	-35.06%4.4M	-2.51%7.18M	-39.59%5.21M	13.86%5.64M
Current changes in cash	-125.49%-1.69M	-224.04%-2.06M	-56.60%-1.75M	-272.76%-3.4M	-725.24%-3.53M	435.82%6.63M	169.91%1.66M	62.28%-1.12M	256.56%1.97M	-111.66%-428.06K
End cash Position	-81.78%2.31M	-33.99%4M	-33.99%4M	-19.88%5.75M	75.76%9.16M	125.07%12.69M	37.74%6.06M	37.74%6.06M	-2.51%7.18M	-39.59%5.21M
Free cash flow	7.93%-2.3M	6.89%-11.19M	26.22%-1.75M	3.56%-3.4M	-9.19%-3.53M	13.14%-2.5M	-57.39%-12.01M	9.22%-2.37M	-59.82%-3.53M	-228.58%-3.24M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall